GENE ONLINE|News &
Opinion
Blog

Sage Therapeutics
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
JPM
JPM23: Development and Strategic Updates from JP Morgan Healthcare Conference 2023 Day Two
2023-01-10
Biogen, Sage Pursue 2022 Filing for Depression Therapy, Zuranolone
2021-10-20
Biogen and Sage Therapeutics Ink Deal for Treating Depression
2020-11-29
GeneOnline’s Top Ten Headlines of the Year
2019-12-30
FDA Approves New Drug for Specific Treatment of Postpartum Depression
2019-03-21
Top 3 Announcements at the J.P. Morgan Healthcare Conference 2019
2019-01-13
LATEST
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Biotech Stock Performance Gap Widens During Second Quarter of 2026
2026-07-11
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
Sean Kaufman Faces Senate Scrutiny Over Past Vaccine Safety Comments Ahead of Confirmation Hearing
2026-07-10
Penn State College of Medicine Receives $2.5 Million Grant for Street Medicine Program
2026-07-10
IBEC and European Researchers Receive Novo Nordisk Foundation Grant to Study Physics of Living Matter
2026-07-10
Scroll to Top